Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats

Nephrology Dialysis Transplantation

Volumn 31, Issue 3, 2016, Pages 401-412

  Yoshifuji, Ayumi ^a   Wakino, Shu ^a   Irie, Junichiro ^a   Tajima, Takaya ^a   Hasegawa, Kazuhiro ^a   Kanda, Takeshi ^a   Tokuyama, Hirobumi ^a   Hayashi, Koichi ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

chronic kidney disease; gut microbiota; protein bound uremic retention solutes; tight junction; Toll like receptor

Indexed keywords

4 CRESYL SULFATE; C REACTIVE PROTEIN; GLYCEROPHOSPHORYLCHOLINE DERIVATIVE; INDICAN; INDOLE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OXIDIZED 1 PALMITOYL 2 ARACHIDONYL SNGLYCERO 3 PHOSPHORYLCHOLINE; PROTEIN; TIGHT JUNCTION PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; UREA; UREMIC TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDES; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; COLON; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; KIDNEY FAILURE; LACTOBACILLUS ACIDOPHILUS; MALE; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; RENAL SCLEROSIS; SCLEROSIS; SPONTANEOUSLY HYPERTENSIVE RAT; SUPPLEMENTATION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DISEASE MODEL; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; BLOOD UREA NITROGEN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; INTESTINES; LACTOBACILLUS; MALE; RATS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84960112689     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv353     Document Type: Article

References (52)

1. Vanholder R, Schepers E, Pletinck A, et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J AmSoc Nephrol 2014; 25: 1897-1907
2. Muteliefu G, Shimizu H, Enomoto A, et al. Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. Am J Physiol Cell Physiol 2012; 303: C126-C134
3. Shimizu H, Yisireyili M, Higashiyama Y, et al. Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-κB and p53 in proximal tubular cells. Life Sci 2013; 92: 143-148
4. Watanabe H, Miyamoto Y, Honda D, et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 2013; 83: 582-592
5. Dou L, Sallée M, Cerini C, et al. The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 2015; 26: 876-887
6. Vanholder R, Glorieux G. The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J 2015; 8: 168-179
7. Ritz E. Intestinal-renal syndrome: mirage or reality? Blood Purif 2011; 31: 70-76
8. Vaziri ND, Yuan J, Khazaeli M, et al. Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am J Nephrol 2013; 37: 518-525
9. Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013; 83: 1010-1016
10. Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014; 25: 657-670
11. Ranganathan N, Patel B, Ranganathan P, et al. Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. Sci World J 2005; 5: 652-660
12. Ranganathan N, Patel BG, Ranganathan P, et al. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J 2006; 52: 70-79
13. Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013; 83: 308-315
14. Rossi M, Klein K, JohnsonDWet al. Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic reviewand meta-analysis. Int J Nephrol 2012; 2012: 631-673
15. Sugano N, Wakino S, Kanda T, et al. T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int 2008; 73: 826-834
16. Saito S, Shimizu H, Yisireyili M, et al. Indoxyl sulfate-induced activation of (pro)renin receptor is involved in expression of TGF-β1 and a-smooth muscle actin in proximal tubular cells. Endocrinology 2014; 155: 1899-1907
17. Itoh Y, Ezawa A, Kikuchi K, et al. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 2012; 403: 1841-1850
18. Wu L, Cox A, Roe C, et al. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 1997; 51: 1553-1567
19. Kelly DJ, Zhang Y, Gow Ret al. Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model. J Am Soc Nephrol 2004; 15: 2619-2629
20. Nagashima K, Hisada T, Sato M, et al. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 2003; 69: 1251-1262
21. Hiraishi A, Iwasaki M, Shinjo H. Terminal restriction pattern analysis of 16S rRNA genes for the characterization of bacterial communities of activated sludge. J Biosci Bioeng 2000; 90: 148-156
22. Takayama F, Taki K, Niwa T. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 2003; 41(Suppl): S142-S145
23. Larsen N, Vogensen FK, van Den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5: e9085
24. Karlin DA, Mastromarino AJ, Jones RD, et al. Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer. J Cancer Res Clin Oncol 1985; 109: 135-141
25. Zuccato E, Venturi M, Di Leo G, et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci 1993; 38: 514-519
26. Hall JE. Digestion and absorption in the gastrointestinal tract. In: Hall JE (ed). Guyton and Hall Textbook of Medical Physiology, 13th edn. Philadelphia, PA: Elsevier, 2015, pp. 833-842
27. Vllasaliu D, Casettari L, Fowler R, et al. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study. Int J Pharm 2012; 430: 151-160
28. Emmelot CH, van Der Waaij D. The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice. J Hyg (Lond) 1980; 84: 331-340
29. McCall IC, Betanzos A, Weber DA, et al. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol Appl Pharmacol 2009; 241: 61-70
30. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007; 132: 1359-1374
31. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241
32. Karczewski J, Troost FJ, Konings I, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010; 298: G851-G859
33. Sakai F, Hosoya T, Ono-Ohmachi A, et al. Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLoS One 2014; 9: e105370
34. Vaziri ND, Goshtasbi N, Yuan J, et al. Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium. Am J Nephrol 2012; 36: 438-443
35. Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in CKD. Am J Nephrol 2013; 37: 1-6
36. Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904
37. Cénit MC, Matzaraki V, Tigchelaar EF, et al. Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim Biophys Acta 2014; 1842: 1981-1992
38. Wong J, Piceno YM, Desantis TZ, et al. Expansion of urease and uricasecontaning, indole-and p-cresol-forming and contraction of short chain fatty acid-producing intestinal bacteria in ESRD. Am J Nephrol 2014; 39: 230-237
39. Ranganathan N, Ranganathan P, Friedman EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 2010; 27: 634-647
40. Schulman G, Berl T, Beck GJ, et al. Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J Am Soc Nephrol 2015; 26: 1732-1746
41. Jenkins SG, Birk RJ, Zabransky RJ. Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance. Antimicrob Agents Chemother 1982; 22: 628-634
42. Yu Q, Wang Z, Yang Q. Lactobacillus amylophilus D14 protects tight junction from enteropathogenic bacteria damage in Caco-2 cells. J Dairy Sci 2012; 95: 5580-5587
43. Ahmad R, Shihab PK, Jasem S, et al. FSL-1 induces MMP-9 production through TLR-2 and NF-κB/AP-1 signaling pathways in monocytic THP-1 cells. Cell Physiol Biochem 2014; 34: 929-942
44. Xu C, Wang Y, Sun R, et al. Modulatory effects of vasoactive intestinal peptide on intestinal mucosal immunity and microbial community of weaned piglets challenged by an enterotoxigenic Escherichia coli (K88). PLoS One 2014; 9: e104183
45. Schroeder JC, Dinatale BC, Murray IA, et al. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry 2010; 49: 393-400
46. Heath-Pagliuso S, Rogers WJ, Tullis K, et al. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 1998; 37: 11508-11515
47. Venkatesh M, Mukherjee S, Wang H, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 2014; 41: 296-310
48. Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens 2012; 21: 587-592
49. Kondo M, Tahara A, Hayashi K, et al. Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats. Naunyn Schmiedebergs Arch Pharmacol 2014; 387: 909-919
50. Shimizu H, Bolati D, AdijiangAet al. NF-kappaB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am J Physiol Cell Physiol 2011; 301: C1201-C1212
51. Yisireyili M, Shimizu H, Saito S, et al. Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. Life Sci 2013; 92: 1180-1185
52. Cummings JH. Absorption and secretion by the colon. Gut 1975; 16: 323-329